Long-Term Survival of a Breast Cancer Patient with Extensive Liver Metastases Upon Immune and Virotherapy: A Case Report
Author(s) -
Volker Schirrmacher,
Wilfried Stücker,
Maria Lulei,
Akos-Sigmund Bihari,
Tobias Sprenger
Publication year - 2015
Publication title -
immunotherapy
Language(s) - English
Resource type - Journals
eISSN - 1750-7448
pISSN - 1750-743X
DOI - 10.2217/imt.15.48
Subject(s) - medicine , virotherapy , breast cancer , immune system , oncolytic virus , cancer , disease , immunotherapy , oncology , quality of life (healthcare) , metastatic breast cancer , immunology , nursing
Liver metastases in breast cancer are associated with a poor prognosis. We report long-term survival of a patient with breast cancer and liver metastases. After operation the patient declined further standard therapy. Instead, she was treated with local hyperthermia, Newcastle disease virus and dendritic cell vaccination at the Immunological and Oncological Center Cologne (IOZK), Germany. A continuous high quality of life was reported and the patient survived more than 66 months after initial diagnosis. No recurrence or further metastases developed under treatment. Following treatment, a long-lasting tumor-reactive memory T-cell responsiveness could be documented. This possibly explains the favorable course of disease. Since this combination of therapies is not restricted to a particular tumor type, further exploration is warranted.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom